Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Future CAGR of the Cancer Supportive Care Products Market, and How Will It Impact Industry Expansion?

Recent years have seen robust growth in the size of the cancer supportive care products market. The market is projected to expand from $21.56 billion in 2024 to $22.65 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.1%. The growth experienced in the historical period can be linked to an increase in cancer cases, heightened awareness and education, advancements in healthcare infrastructure, a rise in the geriatric population, and enhancement in awareness and early diagnosis.

The market size for products supporting cancer care is anticipated to experience constant expansion in the coming years. The estimation predicts an increase to $27.32 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 4.8%. The projected growth within the forecast duration can be credited to several factors. These include the escalating incidence of cancer, the increasing emphasis on patient-focused approaches, surge in investment towards cancer research, the growing interest in individualized medicine and augmenting survival rates of cancer patients. Major trends to be seen in this forecast period encompass technological evolution, sophisticated drug delivery methods, the development of newer drug solutions, customized care, and the creation of biodegradable products.

What Industry-Specific Factors Are Fueling the Growth of the Cancer Supportive Care Products Market?

The cancer supportive care products market is likely to grow due to a rise in cancer incidences. With aging populations, the threat of cancer increases because of cell changes and extended exposure to risk elements. Habits like smoking, poor diet, lack of regular exercise, and heavy drinking majorly heighten the risk of cancer. Supportive care products for cancer help handle symptoms, enhance patients’ quality of life, and assist patients during treatment, addressing the rising need due to the growing frequency of cancer. For example, the American Cancer Society, a non-profit institution based in the US striving towards cancer eradication, projected in January 2024, that oral cavity and pharynx cancer cases were predicted to be 58,450. This prediction shows a 7.2% rise from the 54,540 cases reported in 2023. Hence, a rise in cancer cases will stimulate the growth of the cancer supportive care products market.

Get Your Free Sample of the Global Cancer Supportive Care Products Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=18529&type=smp

What Are the Top Market Players Propelling the Growth of the Cancer Supportive Care Products Industry?

Major companies operating in the cancer supportive care products market are:

• Johnson & Johnson_x000D_

• F. Hoffmann-La Roche Ltd._x000D_

• Merck & Co. Inc._x000D_

• AbbVie Inc._x000D_

• Bayer AG_x000D_

What Are the Key Trends to Watch in the Cancer Supportive Care Products Market Over the Coming Years?

Leading corporations in the cancer supportive care products arena are concentrating on advancements in cancer treatment techniques – such as the targeted radioligand therapy (RLT) platform – in order to increase treatment effectiveness, minimize side effects, and enhance patient results. An RLT platform utilizes radiolabeled molecules that precisely attach to cancer cell markers, delivering localized radiation and selectively killing cancer cells while preserving healthy tissue. For example, in May 2022, Switzerland’s Novartis AG obtained FDA approval for Pluvicto (lutetium Lu 177 vipivotide tetraxetan), a treatment for adult patients with PSMA-positive mCRPC that has advanced despite previous treatments. It’s noteworthy that Pluvicto is the first FDA-approved RLT targeted for suitable mCRPC patients, merging a targeting ligand with a therapeutic radioisotope. Additionally, the FDA has sanctioned Locametz (gallium Ga 68 gozetotide injection), a substance employed in PET scans to identify PSMA-positive lesions, which aids in identifying where the cancer has spread and establishing eligibility for Pluvicto therapy.

Get Instant Access to the Global Cancer Supportive Care Products Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/cancer-supportive-care-products-global-market-report

What Are the Primary Segments of the Cancer Supportive Care Products Market and Their Roles in Growth Dynamics?

The cancer supportive care products market covered in this report is segmented –

1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs, Anti-Infective, Anti-Emetics, Monoclonal Antibodies, Erythropoietin Stimulating Agents, Opioid Analgesics, Bisphosphonates, Granulocyte Colony Stimulating Factor

2) By Indication: Lung Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Bladder Cancer, Leukemia, Ovary Cancer, Melanoma Cancer, Other Indications

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Compounding Pharmacies

Subsegments

1) By Nonsteroidal Anti-Inflammatory Drugs (Nsaids): Ibuprofen, Aspirin, Naproxen

2) By Anti-Infective: Antibiotics, Antifungal Drugs, Antiviral Drugs

3) By Anti-Emetics: 5-Ht3 Antagonists (Ondansetron), Nk1 Antagonists (Aprepitant), Corticosteroids (Dexamethasone)

4) By Monoclonal Antibodies: Rituximab, Trastuzumab, Bevacizumab

5) By Erythropoietin Stimulating Agents: Epoetin Alfa, Darbepoetin Alfa

6) By Opioid Analgesics: Morphine, Fentanyl, Oxycodone

7) By Bisphosphonates: Zoledronic Acid, Pamidronate, Ibandronate

8) By Granulocyte Colony Stimulating Factor: Filgrastim, Pegfilgrastim

What Regions Are Dominating the Cancer Supportive Care Products Market Growth?

North America was the largest region in the cancer supportive care products market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer supportive care products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Characteristics That Define the Cancer Supportive Care Products Market?

Cancer supportive care products refer to a range of medical treatments, therapies, and products designed to manage and alleviate the symptoms, side effects, and complications associated with cancer and its treatments. These products aim to improve the quality of life for cancer patients by addressing various aspects of care, including physical, emotional, and psychological support.

Browse Through More Similar Reports By The Business Research Company:

Pancreatic Cancer Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pancreatic-cancer-drugs-global-market-report

Cancer Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Blood Cancer Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-cancer-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: